PTX - Pernix Therapeutics Holdings, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Pernix Therapeutics Holdings, Inc.

10 North Park Place
Suite 201
Morristown, NJ 07960
United States
800-793-2145
http://www.pernixtx.com

SectorHealthcare
IndustryDrug Manufacturers - Other
Full Time Employees185

Key Executives

NameTitlePayExercisedAge
Mr. John Anthony SedorChairman & CEO982.15kN/A72
Dr. Graham G. Miao M.S., M.B.A., Ph.D.Pres & CFO587.93kN/A53
Mr. Glenn WhaleyPrincipal Accounting Officer, Interim VP of Fin. & Corp. ControllerN/AN/A49
Mr. Kenneth R. Pina Esq.Sr. VP, Chief Legal & Compliance Officer and Corp. Sec.N/AN/A58
Mr. George P. JonesVP of Sales and MarketingN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including neurology, pain, and psychiatry. The company’s products comprise Treximet, a fixed dose combination product indicated for the treatment of acute migraine; Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; and Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.

Corporate Governance

Pernix Therapeutics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.